This study aimed to examine demographic and clinical variables, psychiatric comorbidities,
the prevalence of psychotropic drug use, relationships between drug use, demographic and …

This study examined psychotropic medication use among 7901 children aged 1–17 with
autism spectrum disorder (ASD) in five health systems, comparing to matched cohorts with …

Objective: The aim of this study was to characterize patterns of and factors associated with
psychotropic medication use in children with autism spectrum disorder (ASD) receiving …

TOPIC Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder that
requires a multidisciplinary approach to treatment. Psychopharmacology can play an …

OBJECTIVE: The objectives of this study were to examine rates and predictors of
psychotropic use and multiclass polypharmacy among commercially insured children with …

A review is presented of the article" Psychotropic Medication Use and Polypharmacy in
Children With Autism Spectrum disorders" by D. Spencer, J. Marshall, B. Post, M. Kulakodlu …

OBJECTIVES: The goal of this study was to examine rates of psychotropic medication use
and identify associated child and family characteristics among children and adolescents with …

Little research has been conducted to date on the relationship between psychotropic
medication use and autism spectrum disorders (ASDs). Participants in the current study …

This study reviewed Kentucky Medicaid claims data for children with autism spectrum
disorders to determine psychotropic drug (PTD) use in this population. Children with autism …

This study examined the treatment rates and patterns in children and adolescents with
autism spectrum disorders (ASDs). Data were collected on 353 nonreferred children and …